Financials in USD. Standardized financial statements.
A compact view of how Insmed Incorporated turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $606.42M | $363.71M | $305.21M | $245.36M | $188.46M | $164.41M | $136.47M | $9.84M | $0 | $0 |
| Revenue Growth? | +66.7% | +19.2% | +24.4% | +30.2% | +14.6% | +20.5% | +1287.6% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $124.88M | $85.74M | $65.57M | $55.13M | $44.15M | $39.87M | $24.21M | $2.42M | $2.90M | $2.44M |
| Gross Profit? | $481.55M | $277.96M | $239.63M | $190.23M | $144.31M | $124.54M | $112.25M | $7.41M | -$2.90M | -$2.44M |
| Gross Margin? | +79.4% | +76.4% | +78.5% | +77.5% | +76.6% | +75.7% | +82.3% | +75.4% | 0.0% | 0.0% |
| Operating Expenses? | $1.66B | $1.16B | $949.26M | $647.55M | $519.40M | $389.77M | $347.50M | $314.75M | $188.92M | $173.40M |
| Operating Income? | -$1.18B | -$878.25M | -$709.63M | -$457.32M | -$375.09M | -$265.23M | -$235.25M | -$307.34M | -$188.92M | -$173.40M |
| EBITDA? | -$1.17B | -$818.79M | -$660.18M | -$447.37M | -$383.65M | -$250.37M | -$217.07M | -$295.18M | -$184.09M | -$170.24M |
| Income Before Tax | -$1.27B | -$910.07M | -$747.01M | -$480.15M | -$436.41M | -$292.69M | -$253.56M | -$324.08M | -$192.92M | -$176.18M |
| Income Tax Expense | $5.03M | $3.71M | $2.56M | $1.38M | -$1.76M | $1.40M | $777,000 | $201,000 | -$272,000 | $98,000 |
| Net Income? | -$1.28B | -$913.77M | -$749.57M | -$481.53M | -$434.65M | -$294.09M | -$254.34M | -$324.28M | -$192.65M | -$176.27M |
| EPS? | $-6.41 | $-5.57 | $-5.34 | $-3.91 | $-3.88 | $-3.01 | $-3.01 | $-4.22 | $-2.89 | $-2.85 |
| Diluted EPS? | $-6.41 | $-5.57 | $-5.34 | $-3.91 | $-3.88 | $-3.01 | $-3.01 | $-4.22 | $-2.89 | $-2.85 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality